Not Yet RecruitingPhase 4ACTRN12626000346370

Studying the efficacy of Lidocaine in reducing the incidence of laryngospsam in children undergoing surgical removal of adenoids and tonsills

Efficacy of Intravenous lidocaine in preventing Perioperative respiratory adverse events in children after adenoidectomy and tonsillectomy procedures.


Sponsor

Tamer Hamed Ibrahim ( Sheikh Shakhbout Medical City)

Enrollment

150 participants

Start Date

Apr 1, 2026

Study Type

Interventional

Conditions

Summary

Children undergoing adenotonsillectomy has a high incidence of developing respiratory adverse effects as spasm in the upper airway and drop in their oxygen saturation . lidocaine may be effective in reducing the incidence of such problems in these children . We are going to study its efficacy in reducing the incidence of such complications.


Eligibility

Sex: Both males and femalesMin Age: 1 YearsMax Age: 10 Yearss

Inclusion Criteria1

  • American society of anesthesiologist 1 & 2 Children undergoing adenotonsillectomy

Exclusion Criteria3

  • Children with chronic respiratory disease
  • Children with cardiac disease
  • Allergy to lidocaine

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

- Patients in one of the 2 groups will receive IV lidocaine 5 minutes before extubation - 1.5 mg/kg intravenous - the anesthesiologist will be the one to administer - medical documents will be use

- Patients in one of the 2 groups will receive IV lidocaine 5 minutes before extubation - 1.5 mg/kg intravenous - the anesthesiologist will be the one to administer - medical documents will be used to assess adherence to intervention


Locations(1)

United Arab Emirates

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12626000346370